Synakis
PrivateLast Round
Pre Seed
May 26, 2026
Total Funding Raised
$2.04M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Synakis is a biotechnology company developing novel biomaterial-based treatments for ocular injuries and diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synakis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Synakis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 26, 2026 | ||||
| Accelerator | Mar 12, 2026 |
Key People
Founding team and executive leadership
Synakis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Glycomics Network | Pre Seed |
| TIAP | Pre Seed |
| Ontario Genomics | Accelerator |
| Chiefswood Private Capital Inc. | Pre Seed |
| Ontario Centre of Innovation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$1.89M round led by TIAP and Chiefswood Private Capital.
- Apr 19, 2026
Monthly visitors grew 360% MoM, from 226 to 1K.
Synakis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synakis's valuation, stock price, and market status.